1. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta- analysis of the randomised trials The Lancet Volume 386, Issue 10001, Pages 1341-1352 (October 2015) DOI: 10.1016/S0140-6736(15)61074-1 Copyright © 2015 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

2. Figure 1 The Lancet 2015 386, 1341-1352DOI: (10.1016/S0140-6736(15)61074-1) Copyright © 2015 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

3. Figure 2 The Lancet 2015 386, 1341-1352DOI: (10.1016/S0140-6736(15)61074-1) Copyright © 2015 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

4. Figure 3 The Lancet 2015 386, 1341-1352DOI: (10.1016/S0140-6736(15)61074-1) Copyright © 2015 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

5. Figure 4 The Lancet 2015 386, 1341-1352DOI: (10.1016/S0140-6736(15)61074-1) Copyright © 2015 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

6. Figure 5 The Lancet 2015 386, 1341-1352DOI: (10.1016/S0140-6736(15)61074-1) Copyright © 2015 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions